We have a large portfolio of products, including prescription medicines, vaccines and consumer healthcare brands, across a broad range of therapeutic areas.

All of our medicines are listed in alphabetical order in below table. By clicking on the underlined medicine name in the below table, you will be directed to the electronic Medicines Compendium (eMC), which contains up-to-date information about medicines licensed for use in the UK.  Through this resource, you can access the Patient Information Leaflet (PIL) and Summary of Product Characteristics (SmPC) for all our medicines.

While this information may be helpful it is not intended to replace the advice of a doctor or other prescriber or other health professional.

By clicking on the medicine names in the list below you will leave the sanofi.co.uk website and will go to the medicines.org.uk website which is not operated by Sanofi. Sanofi has no control over the content or availability of linked sites or resources and accepts no liability or responsibility for them or for any loss or damage that may arise from your use of them. The existence of a link between this website and any third-party site or resource in no way implies that Sanofi in any way approves of the content of these sites or resources, or any use to which such content maybe put. Please ensure that you read the legal and privacy policy sections of any third-party site to which you link.

Valproate (Epilim and Depakote) Pregnancy Prevention Programme

Valproate is contraindicated in girls and women of childbearing potential unless the conditions of Prevent – the valproate pregnancy prevention programme are fulfilled.

Valproate Annual Risk Acknowledgement Form (ARAF) 
This ARAF should be completed by girls and women of childbearing potential with their specialist. Your specialist should review your treatment and complete this form with you at least once a year to make sure you know and have understood all the risks related to the use of valproate during pregnancy and the need to avoid becoming pregnant while taking valproate.

Other Educational Materials for Patients taking Valproate

Other Educational Materials for Healthcare Professionals involved in the management of patients taking Valproate

Job bag number MAT-GB-2001218(v2.0)
Date of Preparation January 2022